332 related articles for article (PubMed ID: 18762220)
61. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
62. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
Simondon F; Guiso N
Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
[TBL] [Abstract][Full Text] [Related]
63. Pertussis in Argentina and France.
Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
[TBL] [Abstract][Full Text] [Related]
64. [Genetic variability of Bordetella pertussis strains. Part II. Perspectives].
Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
Przegl Epidemiol; 2003; 57(1):193-200. PubMed ID: 12926328
[TBL] [Abstract][Full Text] [Related]
65. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
[TBL] [Abstract][Full Text] [Related]
66. [Pertussis. Critical revision of its physiopathology. Implications].
Fiore D
Pediatr Med Chir; 1996; 18(1):109-12. PubMed ID: 8685015
[TBL] [Abstract][Full Text] [Related]
67. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.
Kamachi K; Fukuda T; Han HJ; Toyoizumi-Ajisaka H; Mochida K; Konda T; Horiuchi Y; Arakawa Y;
Biologicals; 2010 Mar; 38(2):290-3. PubMed ID: 20064727
[TBL] [Abstract][Full Text] [Related]
68. Will we have new pertussis vaccines?
Locht C
Vaccine; 2018 Aug; 36(36):5460-5469. PubMed ID: 29180031
[TBL] [Abstract][Full Text] [Related]
69. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
[TBL] [Abstract][Full Text] [Related]
70. A live vaccine against pertussis.
Vesselinova-Jenkins CK
Dev Biol Stand; 1985; 61():517-24. PubMed ID: 3835083
[TBL] [Abstract][Full Text] [Related]
71. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing.
Maharjan RP; Gu C; Reeves PR; Sintchenko V; Gilbert GL; Lan R
Res Microbiol; 2008; 159(9-10):602-8. PubMed ID: 18790049
[TBL] [Abstract][Full Text] [Related]
72. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
[TBL] [Abstract][Full Text] [Related]
73. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
74. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
Khosravani A; Parker MC; Parton R; Coote J
Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
[TBL] [Abstract][Full Text] [Related]
75. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo.
Gillespie J; Juhan NM; DiCristina J; Key KF; Ramamoorthy S; Meng XJ
Vaccine; 2008 Aug; 26(33):4231-6. PubMed ID: 18579262
[TBL] [Abstract][Full Text] [Related]
76. Effectiveness of experimental whole-cell pertussis vaccines in murine model.
Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Lutyńska A
Med Dosw Mikrobiol; 2014; 66(2):79-87. PubMed ID: 25369654
[TBL] [Abstract][Full Text] [Related]
77. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
Elomaa A; He Q; Minh NN; Mertsola J
Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
[TBL] [Abstract][Full Text] [Related]
78. Virulence of a Bordetella pertussis strain expressing a mutant adenylyl cyclase with decreased calmodulin affinity.
Oldenburg DJ; Gross MK; Smith AL; Storm DR
Microb Pathog; 1993 Jun; 14(6):489-93. PubMed ID: 8412621
[TBL] [Abstract][Full Text] [Related]
79. Live attenuated B. pertussis BPZE1 rescues the immune functions of Respiratory Syncytial virus infected human dendritic cells by promoting Th1/Th17 responses.
Schiavoni I; Fedele G; Quattrini A; Bianco M; Schnoeller C; Openshaw PJ; Locht C; Ausiello CM
PLoS One; 2014; 9(6):e100166. PubMed ID: 24967823
[TBL] [Abstract][Full Text] [Related]
80. [General immunogenesis after oral uptake of killed Pertussis bacteria].
Hof H; Finger H
Zentralbl Bakteriol Orig A; 1974; 227(1-4):282-8. PubMed ID: 4154597
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
